Advertisement

Chemotherapy pp 295-298 | Cite as

Screening of Enzyme Inhibitors with Potential Antitumor Activity

  • Hamao Umezawa

Abstract

Antitumor antibiotics have been discovered by screening of microbial culture filtrates for activity to inhibit experimental animal tumors which can be conveniently utilized. However, there is no direct relationship between a particular type of human tumor and such experimental animal tumors, and all antitumor antibiotics thus found exhibit cytotoxic action. Methods of testing activity against animal tumors, methods of testing cytotoxic action against cancer cells in culture or in disc plate agar (1), methods of testing mutagenic action, for instance, testing activity to cause induction of lyzogenic phage (2) or to cause mutation of T2 phage from h+ to h (3), have been devised. Biochemical methods (4) to test activity of culture filtrates to inhibit synthesis of protein, RNA and DNA in cancer cell homogenates were also presented.

Keywords

Testing Activity Antitumor Agent Contact Inhibition Ehrlich Ascites Carcinoma Potential Antitumor Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Yamazaki, S., Nitta, K., Hikiji, T., Nogi, M., Takeuchi, T., Yamamoto, T. and Umezawa, H.: Cylinder plate method testing the anti-cell effect. J. Antibiot., 9, 135–140, 1956PubMedGoogle Scholar
  2. 2.
    Lein, J., Heinemann, B. and Gourevitch, A.: Induction of lysogenic bacteria as a method of detecting potential antitumor agents. Nature, 196, 783–784, 1962PubMedCrossRefGoogle Scholar
  3. 3.
    Nakamura, S., Omura, S., Hamada, M., Nishimura, T., Yamaki, H., Tanaka, N., Okami, Y. and Umezawa, H.: Application of mutation of T2 phage from h+ to h to screening of antitumor antibiotics produced by actinomycetes. J. Antibiot., 20, 217–222, 1967PubMedGoogle Scholar
  4. 4.
    Nitta, K., Mizuno, S. and Umezawa, H.: Biochemical method of screening of microbial products exhibiting antitumor activity. J. Antibiot., 19, 282–284, 1966PubMedGoogle Scholar
  5. 5.
    Umezawa, H.: Enzyme Inhibitors of Microbial Origin. Published by the University of Tokyo Press, 1972Google Scholar
  6. 6.
    Együd, L. G. and Szent-Gyorgi, A.: Cell division, SH, ketoaldehydes and cancer. Proc. N.A.S., 55, 388–393, 1966CrossRefGoogle Scholar
  7. 7.
    Egyud, L. G. and Szent-Györgi, A.: On the regulation of cell division. Proc. N.A.S., 56, 203–207, 1966CrossRefGoogle Scholar
  8. 8.
    Alexander, N. M. and Boyer, J. L.: A rapid assay for the glyoxalase enzyme system. Analyt. Biochem., 41, 29–38, 1971PubMedCrossRefGoogle Scholar
  9. 9.
    Mitscher, L. A., Andres, W. W. and McCrae, W.: Reticulol, a new metabolic isocoumarin. Experientia, 20, 258–259, 1964PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Hamao Umezawa
    • 1
    • 2
  1. 1.Institute of Microbial chemistryShinagawa-ku, TokyoJapan
  2. 2.Department of AntibioticsNational Institute of HealthTokyoJapan

Personalised recommendations